Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any early infantile epileptic encephalopathy in which the cause of the disease is a mutation in the NECAP1 gene.
Features include always present findings: Axial hypotonia, Feeding difficulties, Generalized tonic seizure, and Generalized hypotonia and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Generalized tonic seizure, Profound global developmental delay, Brain atrophy |
NECAP1 encodes NECAP endocytosis associated 1 (275 aa). Involved in endocytosis Highest expression in Brain Cerebellar Hemisphere (130.3 TPM) and Brain Cerebellum (92.7 TPM).
Developmental and epileptic encephalopathy, 21 is associated with mutations in the NECAP1 gene on chromosome 12.
NECAP1 is classified as a druggable target with score 0.0.
Genetic testing for NECAP1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for developmental and epileptic encephalopathy, 21 has been reported in the published literature.
Phenotype severity distribution: 11 always present features.
No clinical trials have been registered for developmental and epileptic encephalopathy, 21.
140 publications have been identified in PubMed for developmental and epileptic encephalopathy, 21. Research spans Epidemiology / Natural History (30%), Basic Science / Preclinical (24%), and Review / Meta-Analysis (21%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 42 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
3 |
Axial hypotonia, Generalized hypotonia, Brain atrophy |
Digestive system | 1 | Feeding difficulties |
Arms and legs | 1 | Limb hypertonia |
Pregnancy and birth | 1 | Decreased fetal movement |
Age of onset: at birth.
Laboratory research |
33 |
24% |
Research summaries | 29 | 21% |
Clinical study results | 18 | 13% |
Patient case studies | 11 | 8% |
Testing and diagnosis research | 4 | 3% |
New treatment approaches | 3 | 2% |
Yilmaz Gulec E (2026). [PMID: 42232679](https://pubmed.ncbi.nlm.nih.gov/42232679/). *Mol Syndromol*. [Epidemiology / Natural History]
Briscoe C (2026). [PMID: 41172580](https://pubmed.ncbi.nlm.nih.gov/41172580/). *Pediatr Neurol*. [Review / Meta-Analysis]
GBD 2023 Mental Disorder Collaborators (2026). [PMID: 42167272](https://pubmed.ncbi.nlm.nih.gov/42167272/). *Lancet*. [Review / Meta-Analysis]
Massaroni V (2026). [PMID: 42001857](https://pubmed.ncbi.nlm.nih.gov/42001857/). *Epilepsy Behav*. [Review / Meta-Analysis]
Zhou YQ (2026). [PMID: 41948719](https://pubmed.ncbi.nlm.nih.gov/41948719/). *Front Pharmacol*. [Epidemiology / Natural History]
Li Y (2026). [PMID: 41988220](https://pubmed.ncbi.nlm.nih.gov/41988220/). *Neurol Genet*. [Review / Meta-Analysis]
Reischl-Hajiabadi AT (2026). [PMID: 41728752](https://pubmed.ncbi.nlm.nih.gov/41728752/). *J Inherit Metab Dis*. [Diagnostic / Biomarker]
Li X (2026). [PMID: 41389464](https://pubmed.ncbi.nlm.nih.gov/41389464/). *Seizure*. [Basic Science / Preclinical]
Arshad MN (2026). [PMID: 41709000](https://pubmed.ncbi.nlm.nih.gov/41709000/). *Exp Mol Med*. [Basic Science / Preclinical]
Acharya A (2026). [PMID: 41964217](https://pubmed.ncbi.nlm.nih.gov/41964217/). *HGG Adv*. [Clinical Trial Publication]